ArticleBMC cardiovascular disorders2025

SGLT2-inhibition and myocardial infarction size in patients with type 2 diabetes mellitus- Insights from an acute cardiovascular care center.

Istvan Bojti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.